Radiation oncologist @ClinUnivStLuc and ParTICLe proton therapy centre | Assistant Prof. @UCLouvain_be | President Belgian Association for Neuro-Oncology 🇧🇪🧠
Reducing the irradiation volume in patients with glioblastoma (CTV: 20 -> 15 mm) offers the potential for less treatment toxicity without compromising patient outcome 🧠☢️
This supports the new @ESTRO_RT@EANOassociation guidelines (@MaxNiyazi, 2023)
🔍 https://t.co/SwX5Oq1oWH
New article alert (Volume 168)
Laurien De Roeck et al.
The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation . https://t.co/d6k36CRh6F
https://t.co/qLn6YYXgoi
Pleased to announce our latest work:
"The European Particle Therapy Network (EPTN) consensus on the #follow-up of adult patients with #brain and #skull base tumours treated with #photon or #proton#irradiation" @ESTRO_RT @RadiotherapyOn1
https://t.co/H8L8DDGcsM
Hypofractionated stereotactic body radiation therapy (SBRT) in pediatric patients: preliminary toxicity results of a national prospective multicenter study
https://t.co/DDegPnwxz3
#RadOnc#Radiotherapy#Radiology
Preliminary toxicity results of a national study investigating SBRT in pediatric patients led by Line Claude @CLCCLeonBerard out in @BJR_Radiology ⚡️
➡️ SBRT showed a favorable safety profile in lung, brain, and (para)spinal lesions
🔍 https://t.co/hZBgXBBuWb
#RadOnc#PedOnc
The Department of Paediatric Haematology and Oncology of the Cliniques Universitaires Saint-Luc, Brussels, Belgium, is opening a position for a full-time fellow in training for 2 years from October 2021.
Find out more 👇
https://t.co/uuTPfuJZeR
#YoungSIOPE
The updated EPTN atlas for organs at risk delineation in neuro-oncology is now available online ✏️🧠
The article @Estro_rt#GreenJournal ➡️ https://t.co/eOQ4gfMOdF
The browsable atlas ➡️ https://t.co/m2qiOVak2N
#RadOnc#NeuroOnc
Radiation necrosis (RN) is a significant cause of neurological impairment following different radiation modalities for brain mets. In this study, Perri et al @CLCCLeonBerard determine incidence and risk factors for RN following HFSRT. #btsm#nsgy@NSTumorSection
#PARTICLE, le 1er centre de protonthérapie belge, est mis en service ! 7 patients ont déjà reçu un traitement dans le nouveau centre de l’@UZLeuven, exploité conjointement par des équipes d’UZ Leuven et des @ClinUnivStLuc. Infos sur https://t.co/UnqbLOQ1S0